Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,183 | 67 | 98.4% |
| Gift | $19.40 | 1 | 1.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alcon Vision LLC | $217.95 | 12 | $0 (2024) |
| Kala Pharmaceuticals, Inc. | $167.31 | 12 | $0 (2022) |
| Sight Sciences, Inc. | $156.26 | 2 | $0 (2023) |
| Oyster Point Pharma, Inc. | $124.83 | 8 | $0 (2024) |
| Bausch & Lomb Americas Inc. | $121.78 | 8 | $0 (2024) |
| Johnson & Johnson Surgical Vision, Inc. | $62.28 | 2 | $0 (2020) |
| Allergan, Inc. | $54.81 | 4 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $54.70 | 4 | $0 (2018) |
| Tarsus Pharmaceuticals, Inc. | $54.47 | 3 | $0 (2024) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $41.84 | 3 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $249.91 | 14 | Alcon Vision LLC ($79.58) |
| 2023 | $211.69 | 12 | Alcon Vision LLC ($93.92) |
| 2022 | $244.94 | 9 | Sight Sciences, Inc. ($132.39) |
| 2021 | $169.40 | 12 | Kala Pharmaceuticals, Inc. ($83.18) |
| 2020 | $146.15 | 9 | Kala Pharmaceuticals, Inc. ($39.11) |
| 2019 | $111.71 | 7 | Kala Pharmaceuticals, Inc. ($30.03) |
| 2018 | $50.42 | 4 | Novartis Pharmaceuticals Corporation ($36.23) |
| 2017 | $18.47 | 1 | Novartis Pharmaceuticals Corporation ($18.47) |
All Payment Transactions
68 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/20/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 11/13/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/16/2024 | Oyster Point Pharma, Inc. | RYZUMVI (Drug), TYRVAYA | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: Pharmacologically-induced mydriasis | ||||||
| 10/15/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: Ophthalmology | ||||||
| 08/28/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 08/08/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: Ophthalmology | ||||||
| 08/01/2024 | Alcon Vision LLC | EYSUVIS (Drug) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: Ophthalmology | ||||||
| 07/11/2024 | Bausch & Lomb Americas Inc. | INFUSE (Device) | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: Ophthalmology | ||||||
| 06/01/2024 | Alcon Vision LLC | LenSx (Device) | Food and Beverage | In-kind items and services | $24.53 | General |
| Category: Ophthalmology | ||||||
| 05/29/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: Dry eyes | ||||||
| 03/21/2024 | Alcon Vision LLC | Clareon (Device) | Food and Beverage | In-kind items and services | $23.73 | General |
| Category: Ophthalmology | ||||||
| 02/28/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: Dry eyes | ||||||
| 02/14/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 02/07/2024 | Alcon Vision LLC | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: Ophthalmology | ||||||
| 12/20/2023 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: DRY EYE | ||||||
| 12/11/2023 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: Ophthalmology | ||||||
| 10/30/2023 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: Ophthalmology | ||||||
| 10/26/2023 | Alcon Vision LLC | EYSUVIS (Drug) | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: Ophthalmology | ||||||
| 10/04/2023 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: DRY EYE | ||||||
| 08/02/2023 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: DRY EYE | ||||||
| 06/15/2023 | Alcon Vision LLC | Clareon (Device) | Food and Beverage | In-kind items and services | $24.53 | General |
| Category: Ophthalmology | ||||||
| 05/31/2023 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: Ophthalmology | ||||||
| 04/26/2023 | Alcon Vision LLC | Simbrinza (Drug) | Food and Beverage | In-kind items and services | $19.56 | General |
| Category: Ophthalmology | ||||||
| 03/17/2023 | Alcon Vision LLC | Simbrinza (Drug) | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: Ophthalmology | ||||||
| 03/15/2023 | Sight Sciences, Inc. | TEARCARE SYSTEM (Device) | Food and Beverage | In-kind items and services | $23.87 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 2,497 | 3,364 | $859,637 | $322,939 |
| 2022 | 13 | 2,302 | 3,123 | $713,445 | $289,361 |
| 2021 | 12 | 1,877 | 2,480 | $509,800 | $216,619 |
| 2020 | 12 | 1,566 | 1,986 | $391,135 | $170,924 |
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2023 | 136 | 225 | $438,150 | $105,214 | 24.0% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 676 | 940 | $164,702 | $93,372 | 56.7% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 240 | 478 | $56,560 | $34,275 | 60.6% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 242 | 242 | $53,465 | $27,084 | 50.7% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 251 | 324 | $29,640 | $16,359 | 55.2% |
| 92133 | Imaging of optic nerve | Office | 2023 | 270 | 359 | $26,925 | $10,315 | 38.3% |
| 92134 | Imaging of retina | Office | 2023 | 169 | 208 | $12,060 | $6,837 | 56.7% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Facility | 2023 | 20 | 22 | $10,500 | $5,968 | 56.8% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2023 | 131 | 149 | $13,450 | $5,821 | 43.3% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Office | 2023 | 11 | 11 | $22,000 | $5,170 | 23.5% |
| 92025 | Ct scan of cornea | Office | 2023 | 122 | 148 | $9,505 | $4,358 | 45.9% |
| 92250 | Photography of the retina | Office | 2023 | 100 | 113 | $7,870 | $3,369 | 42.8% |
| 92136 | Measurement of corneal curvature and depth of eye | Facility | 2023 | 84 | 90 | $7,680 | $2,364 | 30.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 13 | 14 | $3,150 | $1,554 | 49.3% |
| 76519 | Ultrasound scan to determine eye length and lens power | Facility | 2023 | 19 | 19 | $1,840 | $492.48 | 26.8% |
| 76519 | Ultrasound scan to determine eye length and lens power | Office | 2023 | 13 | 22 | $2,140 | $386.38 | 18.1% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2022 | 112 | 188 | $300,800 | $88,570 | 29.4% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 578 | 782 | $136,840 | $75,973 | 55.5% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 299 | 517 | $62,040 | $38,013 | 61.3% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 214 | 214 | $42,800 | $24,367 | 56.9% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 237 | 314 | $37,680 | $15,975 | 42.4% |
| 92133 | Imaging of optic nerve | Office | 2022 | 260 | 342 | $25,650 | $9,710 | 37.9% |
| 66982 | Complex removal of cataract with insertion of prosthetic lens | Facility | 2022 | 14 | 15 | $30,000 | $9,659 | 32.2% |
| 76519 | Ultrasound scan to determine eye length and lens power | Office | 2022 | 124 | 220 | $22,000 | $5,568 | 25.3% |
| 92134 | Imaging of retina | Office | 2022 | 113 | 135 | $10,125 | $4,464 | 44.1% |
About Dr. Prinze Mack, M.D
Dr. Prinze Mack, M.D is a Ophthalmology healthcare provider based in Oakhurst, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/16/2007. The National Provider Identifier (NPI) number assigned to this provider is 1609990613.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Prinze Mack, M.D has received a total of $1,203 in payments from pharmaceutical and medical device companies, with $249.91 received in 2024. These payments were reported across 68 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($1,183).
As a Medicare-enrolled provider, Mack has provided services to 8,242 Medicare beneficiaries, totaling 10,953 services with total Medicare billing of $999,842. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Practice Information
- Specialty Ophthalmology
- Location Oakhurst, NJ
- Active Since 03/16/2007
- Last Updated 01/29/2019
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1609990613
Products in Payments
- INVELTYS (Drug) $167.31
- OMNI(R) SURGICAL SYSTEM (US) (Device) $132.39
- TYRVAYA (Drug) $110.47
- Simbrinza (Drug) $77.24
- XDEMVY (Drug) $54.47
- Clareon (Device) $48.26
- EYSUVIS (Drug) $37.40
- XIIDRA (Drug) $33.78
- MIEBO (Drug) $31.25
- DUREZOL (Drug) $30.95
- OXERVATE (Drug) $30.25
- INFUSE (Device) $28.94
- Tecnis Multifocal Family of 1-piece IOLS (Device) $28.63
- Rocklatan (Drug) $28.25
- VYZULTA (Drug) $27.81
- DURYSTA (Drug) $25.60
- LenSx (Device) $24.53
- TEARCARE SYSTEM (Device) $23.87
- None Specified (Medical Supply) $19.40
- TEPEZZA (Biological) $16.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.